Breaking

JPMorgan marks 1,000th branch opening since 2018 expansion plans
Trump takes jab at GOP senator, urging Republicans to ‘vote the exact opposite of’ how she does
Silver Crown Announces Amendment
Trump Clashes With Reporter Over Tariffs, Citing Pandemic and ‘Fighting Lunatics’
Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement
Apple crushes Wall Street expectations as iPhone sales soar
Longtime Biden aide testifies he stood to earn up to $8M had president won re-election
Secret Service must ‘course correct’ after alleged smuggling episode on Trump trip, former agent says

Politics
Business
World
Investing
Search for:

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Silver Crown Announces Amendment

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement

North Shore Uranium: Unlocking Value Across Two World-class Uranium Districts in North America

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (8)
- Investing (50)
- Politics (66)

Disclaimer: readatwill.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2024 readatwill.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.